• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Obituary Notice: Russell “Russ” Haines

    Abenza Chooses North Carolina for New Biologics Manufacturing Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Arkema Recruits Dotmatics as its R&D Digitalization Partner
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Reed-Lane

    Baxter BioPharma Solutions

    Alcami

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Alcami

    Adare Pharma Solutions

    Almac Group

    Syngene
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Biosimilars on the Horizon

    The emerging biosimilar market is ripe with opportunities for CROs and CMOs to imprint their brand

    Related CONTENT
    • Ensuring Pharma Manufacturing Quality
    • Vetter Commercial Manufacturing
    • Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
    • RBQM Comes of Age: COVID as a Catalyst for Change
    • Advanced Analytics Advancing Development of Genetic Vaccines
    Cliff Echols, Bluebox Research10.07.15
    While attending the annual Contract Pharma Conference last month, I decided to take full advantage of the opportunity before me to speak with as many decision makers from pharmaceutical companies as possible. As a market researcher in the contract pharmaceutical manufacturing market, peeking inside the inner workings of how pharmaceutical companies partner with contract research organizations (CROs) or contract manufacturing organizations (CMOs) is my modus operandi. Although the main purpose of these micro-meetings was networking, as a market researcher I couldn’t help but wonder if their views on outsourcing would complement or contradict our own research findings. 

    Using a hot topic issue—biosimilar outsourcing—I asked these decision makers to help me understand the basic thought process of a pharmaceutical company choosing to outsource a product, which could very well be the next blockbuster. As I was listening for the drivers which would be significant in shifting a pharmaceutical company’s opinion, I began to see a pattern of responses matching those from market research conducted earlier in the year. 

    The most common response I was given when considering the outsourcing drivers for biosimilar outsourcing was lower costs of manufacturing. In an infant market like that of biosimilars, manufacturing equipment is highly specialized, and expensive; difficult to locate; and costly to install. For these reasons many companies investigate the ROI on CMO partnerships and rarely look back.
    Perhaps tied with manufacturing cost for the top reason pharmaceutical companies choose to outsource is to benefit from greater technical expertise. The core of CROs and CMOs existence comes from their ability to offer highly specialized solutions in the form of technical expertise. Thus, the emerging biosimilar market is ripe with opportunities for CROs and CMOs to imprint their brand.
    I have paraphrased the third most common response as ‘opportunity cost.’  Opportunity cost exists when a company is faced with making a decision between two choices each with their own set of pros and cons. The opportunity costs are typically associated with the cons in these lists. There are some industries where opportunity cost isn’t a big factor in their strategic planning—the pharmaceutical industry is not one of them. This is because opportunity cost is most applicable when considering long-term actions. 

    At this point any statisticians reading may be thinking, “Ok, you’ve conducted a weak qualitative assessment at best, why is this significant?” The purpose of walking around and speaking with these professionals was to see if my real world experiences and interactions would match the data found by our online surveys. In this case, the micro-meetings confirmed previously collected data. But is that enough? As a final validation check, we should also ask ourselves if these responses make sense in context?

    The two fundamentals to B2B agreements are:
    1) Can you save your client time?
    2) Can you save your client money?

    If we take a look at our identified drivers in the scope of these fundamentals, we begin to see a very clear picture of drivers, which save time, money and sometimes both. So yes, these drivers do make sense within our context. Now what?

    Well, if I were a CRO or CMO looking to get in on a piece of the biosimilar action I would make sure my marketing plan hits on all three of these ‘pain points.’  Make sure to communicate that your manufacturing processes not only help to reduce costs, but you have implemented process optimization, which also helps to save your client time. Talk about how your technical expertise can save time when issues may arise, but also how this expertise helps you to reduce their costs through unique innovations. When it comes to opportunity costs, show your clients how your partnership benefits them in the short and long run.


    Cliff Echols
    Bluebox Research

    Cliff Echols is market research director at Bluebox Research. He is responsible for managing client relationships and client satisfaction with the firm’s custom research project deliveries and oversees the entire research process from identification of client needs, defining a research objectives, preparing research methodology, supervising panel member quality control, fielding supervision, data analysis, and innovative visual reporting. He can be reached at cliff.echols@blueboxresearch.com, or visit the firm online at www.blueboxresearch.com
    Related Searches
    • contract pharma conference
    • Contract Research
    • Pharmaceutical manufacturing
    • Pharma
    Suggested For You
    Ensuring Pharma Manufacturing Quality Ensuring Pharma Manufacturing Quality
    Vetter Commercial Manufacturing Vetter Commercial Manufacturing
    Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
    RBQM Comes of Age: COVID as a Catalyst for Change RBQM Comes of Age: COVID as a Catalyst for Change
    Advanced Analytics Advancing Development of Genetic Vaccines Advanced Analytics Advancing Development of Genetic Vaccines
    Fast Track Automation in Pharmaceutical Manufacturing Fast Track Automation in Pharmaceutical Manufacturing
    Raybow Pharmaceutical Expands in U.S. Raybow Pharmaceutical Expands in U.S.
    Regulatory Practices in a Post-Pandemic World Regulatory Practices in a Post-Pandemic World
    Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
    Catalent Expands Partnership with J&J Catalent Expands Partnership with J&J
    PCI Pharma Services Expands Cold Chain Clinical Supply Storage PCI Pharma Services Expands Cold Chain Clinical Supply Storage
    Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
    Outsourcing Solid Dosage Manufacturing Outsourcing Solid Dosage Manufacturing
    Sharp Appoints EU Qualified Person Sharp Appoints EU Qualified Person
    Jubilant Therapeutics Appoints Chief Scientific Officer Jubilant Therapeutics Appoints Chief Scientific Officer

    Related Back Page

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biogenerics Progress

      Biogenerics Progress

      Generic makers target big forays into major markets
      S. Harachand, Contributing Editor 06.12.18


    • Analytical Services | Biosimilars

      How to Build Better Proteins

      Advancing the next generation of biologics
      Aileen Ruff, Catalent 03.09.16

    • Biosimilars

      Biopharma Nomenclature

      Citizen petition requests biopharmaceutical names and information be disclosed by FDA
      Ronald A. Rader, Biotechnology Information Institute 09.05.13

    Trending
    • Thermo Fisher Acquires PPD For $17.4B
    • Ensuring Pharma Manufacturing Quality
    • Abenza Chooses North Carolina For New Biologics Manufacturing Site
    • Bristol Myers Squibb Expands At Cambridge Crossing
    • Executive Moves: Novavax
    Breaking News
    • Bristol Myers Squibb Expands at Cambridge Crossing
    • Amgen Completes Five Prime Acquisition
    • Sartorius Expands in the UK
    • Obituary Notice: Russell “Russ” Haines
    • Abenza Chooses North Carolina for New Biologics Manufacturing Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Evonik Highlights Solutions for Malodor Reduction
    P&G Emphasizes Small Actions at Home To Be More Sustainable
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login